THERIOSOL

Indicaton

- Antibiotic replacement
- broad antimicrobial spectrum (bacteria - fungi)
- human and veterinary health - medical devices
- lowering antibiotic dose
- lowering antiparasitic dose
- extending scope of action of a done antibiotic (G+ to G-)
- preclinical on sepsis murin model (Acinetobacter baumannii)

Therapeutic indications

Infectious disease

Type of product

Small molecule

Table

Phase

Discovery
Partnering status

Partnered
Partner

THERIOPHARM (BE) for artificial reproduction
Available in

worldwide

You may also be interested in

OligoPhore / SemaPhore / CycloPhore Peptide-Based RNA Delivery Platforms

Delivers siRNA, antisense oligonucleotides, linear or circular mRNA and other RNA modalities to extrahepatic tissues - demonstrated across various indications in oncology (e.g. PDAC, breast cancer, ovarian cancer, lung cancer, melanoma, ATLL, TME), and inflammatory / autoimmune diseases (e.g. OA, RA, enterocolitis), CV (e.g. atherosclerosis, aortic aneurysm)

Discovery

Cadazolid

Crohn's disease

Phase II started

Zevtera / Mabelio (ceftobiprole)

Acute bacterial skin and skin structure infections (ABSSSI)

Phase III completed